Press Releases

Share

Tikcro Technologies Reports Third Quarter 2017 Results

In-progress of Pre Clinical Trials of Full-Human CTLA-4 Antibodies

TIKRF (Ordinary Share)

Last price;
Change (%)
Volume
Data as of 2018-02-25
Minimum 20 minute delay
Refresh quote
© Copyright 2015, Tikcro Ltd. | Legal - Terms of use | All rights reserved | Site by Imaginet